This brings the amount raised by the company to nearly $50 million.
Intel Capital led the Series B. Other investors in Exo include: Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund, and Wanxiang Healthcare Investments.
Exo Imaging Inc. (Redwood, Calif.) is using patented piezoelectric micromachined ultrasonic transducer (pMUT) technology and artificial intelligence (AI) for imaging and therapeutic applications. The goal is to produce a handheld imager than can be affordable and widely available.
"Our mission is to fundamentally change the economics, usability and accessibility of high-quality medical imaging and therapeutic tools,” said Sandeep Akkaraju, CEO at Exo, in a statement. "Our Series B financing will enable us to advance our products through the FDA 510K clearance process and into commercialization," he added.
Related links and articles: